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Abstract 
Aim:  
Pseudomonas aeruginosa (Ps. aeruginosa) considered as most important bacteria which can isolated from 
various kinds of infection. This study tries to survey the infections caused by Ps. aeruginosa especially medical 
and surgical care units and try to reveal the antimicrobial agents susceptibility against Ps. aeruginosa. 
Material and Method:  
This study was conducted during September 2012 to February 2013. During this period total of 285 samples 
were tested and showed growth of bacteria. The isolates of Pseudomonas aeruginosa were selected on the basis 
of their growth on Nutrient agar pigmented and non-pigmented colonies with oxidase positive and on routine 
MacConkey medium which showed lactose Non-fermenting pale colonies. Antimicrobial susceptibility of all the 
isolates was performed using disc-diffusion (Modified-Kirby Baur method) according to CLSIs guidelines. 
Result:  
In present study, maximum isolates of Ps. aeruginosa isolated from various samples. The isolates were obtained 
from different clinical specimens, including pus, urine, respiratory fluids, blood, tissue, and genitalia. All the 
clinically isolated samples were identified as P. aeruginosa. Out of 285, 74.04% are males and 25.96% are 
females. Most of patients were aged between 27-48 years. Approximately half the isolates tested were from 
community patients, mostly from infections of the Wound/Pus (22.46%), urinary tract (22.11%), Swab (18.6%) 
and Respiratory Tract (15.09%). P. aeruginosa strains screened showed sensitivity to AK \Amikacin, E 
\Erythromycin and P\Penicillin while showed resistance to penicillin, erythromycin, and norfloxacin, AX 
\Amoxicillin, AMC \Amoxicillin + Clavulanic acid, AZM \Azithromycin.  
Conclusion:  
To prevent the spread of the resistant bacteria, it is critically important to have strict antibiotic policies while 
surveillance programs for multidrug resistant organisms and infection control procedures need to be 
implemented. 
 
Introduction 
Pseudomonas aeruginosa is inherently resistant to many antimicrobial agents owing to impermeability, multi-
drug efflux and a chromosomal AmpC β-lactamase [1]. Pseudomonas aeruginosa is gram negative rod, an 
aerobic, motile bacterium which belongs to pseudomonadaceae family [2].  
It had the ability to cause nosocomial infections, especially among patients who are admitted to intensive care 
units (ICU). Many infections like severe burns, nosocomial pneumonias, urinary tract infections (UTIs), skin and 
soft tissue infections and in infections of immunocompromised individuals were caused by this bacterium. Of 
particular concern is the limited number of effective Anti-Pseudomonal agents which are used in the therapeutic 
practice, due to the constitutive low level resistance to several agents and the multiplicity of the mechanisms of 
resistance in P. aeruginosa [3].  
Its general resistance is due to a combination of factors [4]. It is intrinsically resistant to antimicrobial agents, 
due to the low permeability of its cell wall. It has the genetic capacity to express a wide repertoire of resistance 
mechanisms. It can become resistant through mutations in the chromosomal genes which regulate the resistance 
genes. It can acquire additional resistance genes from other organisms via plasmids, transposons and 
bacteriophages. In recent years, a considerable increase in the prevalence of multidrug resistance (MDR) in P. 
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aeruginosa has been noticed, which is related to high morbidity and mortality [3 and 5].  
Regional variations in the antibiotic resistance exist for different organisms, including P. aeruginosa and this 
may be related to the difference in the antibiotic prescribing habits. Over the past few years, a notable increase in 
antibiotic resistance among gram negative bacteria recovered from hospitalized patients has been reported, 
especially for critically ill patients [6].  
Infections caused by multidrug resistant (MDR) gram negative bacteria, especially MDR P. aeruginosa have 
been associated with increased morbidity, mortality and costs [7]. Multidrug-resistant strains of P. aeruginosa are 
often isolated among patients suffering from nosocomial infections particularly those receiving intensive care 
treatments [8]. 
The aim of this study was to assess the current levels of antimicrobial susceptibility and to evaluate the 
resistance mechanisms to Anti-Pseudomonal antimicrobial agents among the clinical isolates of P. aeruginosa 
isolated from patients admitted to Educational Al-Hillah hospital and Babylon Maternity and Children hospital in 
Iraq. 
 
Materials and Methods  
Two hundred and eighty five clinical isolates of P. aeruginosa strains were collected from different patients who 
were admitted to Educational Al-Hillah hospital and Babylon Maternity and Children hospital as well as out 
clinic from September 2012 to February 2013. The isolates were obtained from different clinical specimens, 
including pus, urine, respiratory fluids, blood, tissue, and genitalia. All the clinically isolated samples were 
identified as P. aeruginosa by the hospital personnel. The study was therefore carried out using both manual 
(Kirby-Bauer method) as well as automated (Vitek2 system) method to determine the Antimicrobial 
susceptibility pattern of pseudomonas aeruginosa isolates from in-patients and out-patients attending the 
microbiology section of the hospitals. We have identified all the isolates again at our Laboratory by the 
conventional biochemical tests i.e., gram staining, catalase test, oxidase test , motility test, Triple Sugar Iron 
Assay, citrate test, urease test and indole test etc. [9]. 
Also using VITEK 2, which is a 64-well plastic card containing 41 fluorescent biochemical tests, including 18 
enzymatic tests for aminopeptidases and osidases. Substrates used for detection of aminopeptidases are usually 
coupled with 7-amino methylcoumarin (7AMC); substrates for detection of oxidases are usually coupled with 4-
methylumbelliferone (4MU). In addition there are 18 fermentation tests, 2 decarboylase tests, and 3 
miscellaneous tests. There are two negative control wells, and the remaining wells are empty. Results are 
interpreted by the ID-GNB database after a 3-hr incubation period. 
 
Antibiotic susceptibility testing  
The Kirby-Bauer disk diffusion method was performed to determine the antibiotic susceptibility [10]. The 
antibiotics tested were: 
AK \Amikacin, AX \Amoxicillin, AMC \Amoxicillin + Clavulanic acid, AZM \Azithromycin, , B \Bacitracin, PY 
\Carbenicillin, CDZ \Cefodizime, FOX \Cefoxitin, ZOX \Ceftizoxime, CL \Cephalexin, C \Chloromphenicol, 
CLR \Clarithromycin, DA \Clindamycin, E \Erythromycin, CN\Gentamycin, K\Kanamycin, L\Lincomycin, 
ME\Methicillin, F\Nitrofurantoin, NOR\Norfloxacin, OFX \Ofloxacin, OX\Oxacillin, T\Oxytetracyclin, 
P\Penicillin  G, PRL \Piperacillin, RA\Rifampim. Results of disk diffusion method were interpreted in 
accordance to the Clinical and Laboratory Standards Institute (CLSI, 2009) 
 
Results and Discussion 
Two hundred and eighty five clinical isolates of P. aeruginosa strains were collected from different patients who 
were admitted to Educational Al-Hillah hospital and Babylon Maternity and Children hospital as well as out 
clinic from September 2012 to February 2013. The isolates were obtained from different clinical specimens, 
including pus, urine, respiratory fluids, blood, tissue, and genitalia. All the clinically isolated samples were 
identified as P. aeruginosa. 
P. aeruginosa is one of the important causes of morbidity among hospital patients; it is emerged as an important 
pathogen and responsible for the nosocomial infection as showed in table1. 
Out of 285, 74.04% are males and 25.96% are females as showed in table 2. Most of patients were aged between 
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27-48 years. Most of samples were collected from surgical wards, followed by medical ward, pediatrics ward; 
obstetrics ward orthopedic, gynecology and ICU. Maximum resistant isolates of Pseudomonas aeruginosa were 
isolated from wounds and pus/swab samples. 
Approximately half the isolates tested were from community patients (Table 3), mostly from infections of the 
Wound/Pus (22.46%), urinary tract (22.11%), Swab (18.6%) and Respiratory Tract (15.09%).  
Some studies have shown that males were more susceptible than females in the ratio of 8:3 [11]. Previous studies 
have shown that males were more susceptible than females in the ratio of 2:1, which is in accordance with the 
current study. Predominance of male over female patients as shown in the study can be explained by the fact that 
in our province males are exposed more to the outside environment because of their mobility as compared to 
females. 
Some studies reported the prevalence of Pseudomonas species to be 18.79% from a diabetic center in Chennai 
[12]. In a similar study conducted in a private hospital in Chennai, 29.8% strains among diabetic foot ulcer 
patients were P. aeruginosa [13]. This finding shows the high prevalence of Pseudomonas species and P. 
aeruginosa among diabetes patients with foot ulcers. 
The unique feature of P. aeruginosa is its resistance to a variety of antibiotics, which is attributed to a low 
permeability of the cell wall, the production of inducible cephalosporinsaes, an active efflux and a poor affinity 
for the target (DNAgyrase) [14]. 
The Mueller Hinton agar based anibiograms pattern study of P. aeruginosa isolated from different sources is 
shown in Figure 1. Some of the P. aeruginosa strains screened showed sensitivity to AK \Amikacin, E 
\Erythromycin and P\Penicillin while showed resistance to penicillin, erythromycin, and norfloxacin, AX 
\Amoxicillin, AMC \Amoxicillin + Clavulanic acid, AZM \Azithromycin, , B  \Bacitracin, PY \Carbenicillin, 
CDZ \Cefodizime, FOX \Cefoxitin, ZOX \Ceftizoxime, CL  \Cephalexin, C \Chloromphenicol, CLR 
\Clarithromycin, DA \Clindamycin, CN\Gentamycin, K\Kanamycin, L\Lincomycin, ME\Methicillin, 
F\Nitrofurantoin, NOR\Norfloxacin, OFX \Ofloxacin, OX\Oxacillin, T\Oxytetracyclin, G, PRL \Piperacillin, 
RA\Rifampim. 
Because of the increasing resistance to fluroquinolone in many hospitals, its empirical usage is either banned or 
restricted, to bring the developing resistance rates under control9. Ceftazidime and cefepime are the most 
frequently prescribed third and fourth generation cephalosporins respectively. The resistance to Cefodizime was 
reported as 4-18%, but in our study, it was more than 85%. These high values of resistance which were observed 
were comparable to those of the reports from Gujarat, with a resistance value of 75% [15]. The increased 
prevalence of ceftazidime resistant P. aeruginosa is related to the increased use of beta lactam antibiotics such as 
amoxicillin and ceftazidime. Selective pressure from the use of antimicrobial agents is a major determinant for 
the emergence of resistant strains. 
In conclude; although multidrug resistance has commonly been reported in nosocomial P. aeruginosa infections, 
community acquired data have less frequently been reported. For this reason, epidemiological studies on the 
prevalence and antimicrobial susceptibility pattern of the resistant isolates in different geographical settings 
would provide useful information in order to guide clinicians in their choice of therapy and to contribute to the 
global picture of antimicrobial resistance. Rigorous monitoring of the MDR in P. aeruginosa, the restriction of 
the inappropriate use of antimicrobial agents and adherence to infection control practices should be emphasized 
in order to delay the emergence of clinically significant P. aeruginosa. 
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Table 1: Total number of isolates in different specimen 
Total No. of samples 586 
Positive for P. aeruginosa 280 
 
 
 
 
 
Table 2: Sex wise distribution of cases 
Sex Total no Percentage (%) 
Male 211 74.04 
Female 74 25.96 
Total 280 100 
 
 
 
 
Table 3: Isolation of Pseudomonas aeruginosa from different clinical samples 
Name of sample 
No. of Sample in which Pseudomonas 
aeruginosa Isolated 
% 
Pus 3 1.05 
Sputum 12 4.21 
Urine 63 22.11 
Swab 53 18.60 
Stool 16 5.61 
Respiratory Tract 43 15.09 
Wound/Pus 64 22.46 
I/V Line Tips 14 4.91 
Ear 6 2.11 
Eye 3 1.05 
Genitalia 8 2.81 
Total 285 100 
 
 
Journal of Natural Sciences Research                                                                                                 www.iiste.org 
ISSN 2224-3186 (Paper)   ISSN 2225-0921 (Online) 
Vol.3, No.3, 2013 
 
74 
 
AK \Amikacin, AX \Amoxicillin, AMC \Amoxicillin + Clavulanic acid, AZM \Azithromycin, , B \Bacitracin, PY 
\Carbenicillin, CDZ \Cefodizime, FOX \Cefoxitin, ZOX \Ceftizoxime, CL \Cephalexin, C \Chloromphenicol, 
CLR \Clarithromycin, DA \Clindamycin, AK \Amikacin, AX \Amoxicillin, AMC \Amoxicillin + Clavulanic acid, 
AZM \Azithromycin, , B \Bacitracin, PY \Carbenicillin, CDZ \Cefodizime, FOX \Cefoxitin, ZOX \Ceftizoxime, 
CL \Cephalexin, C \Chloromphenicol, CLR \Clarithromycin, DA \Clindamycin 
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Figure 1 : Antimicrobial susceptibility patterns of Pseudomonas 
aeruginosa 
Sensative Pseudomonas aeruginosa 
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